NewCelX Ltd. (NCEL) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$3.16

From 52W high−87.14%

Volume2470.00

Market cap$16.96M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$3.16

From 52W high

−87.14%

Volume

2470.00

Market cap

$16.96M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.7x

P/E (TTM)

—

RSI (14)

44.6

MomentumView details →

1D Return

−6.80%

YTD Return

+70.79%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−4.7x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

29.31%

ROA (TTM)

18.57%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+67.39%

FCF YoY

+51.41%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+91.79%

EBITDA YoY

+8.84%

MomentumView details →

1D Return

−6.80%

YTD Return

+70.79%

1Y Return

−84.09%

RSI (14)

44.6

vs 50D SMA

−6.87%

vs 200D SMA

+4.73%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

0.76x

Quick Ratio

0.76x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.53

EPS Surprise

0.00%

Beats (12Q)

4/12

Next Q EPS Est

—

Avg Surprise (4Q)

73.48%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−720101.00

Op. CF (TTM)

−7.69M

Next earningsMar 3, 2027 →

Latest newsMore news →

NewcelX priced a $1.4 million private equity financing at a 20% premium to support its lead Type 1 Diabetes program.51d ago

Similar companies

Dyadic International, Inc.DYAI Nutriband Inc.NTRBW Citius Pharmaceuticals, Inc.CTXR Pasithea Therapeutics Corp.KTTA BioCardia, Inc.BCDA Akari Therapeutics, PlcAKTX Find similar companies →

Latest newsMore news →

NewcelX priced a $1.4 million private equity financing at a 20% premium to support its lead Type 1 Diabetes program.51d ago